• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浸润性肺腺癌国际肺癌研究协会组织学分级系统验证研究。

Validation Study of the International Association for the Study of Lung Cancer Histologic Grading System of Invasive Lung Adenocarcinoma.

机构信息

Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.

Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.

出版信息

J Thorac Oncol. 2021 Oct;16(10):1753-1758. doi: 10.1016/j.jtho.2021.04.008. Epub 2021 Apr 24.

DOI:10.1016/j.jtho.2021.04.008
PMID:33905897
Abstract

INTRODUCTION

A histologic grading system for invasive lung adenocarcinoma (ADC) has been proposed by the International Association for the Study of Lung Cancer (IASLC) Pathology Committee in June 2020. This study evaluated the prognostic value of the IASLC histologic grading system (the IASLC system) in a large Japanese cohort.

METHODS

We performed comprehensive histologic subtyping using the semiquantitative estimation of five major patterns and complex glandular patterns in patients with a completely resected lung ADC and determined the histologic grade using the IASLC system. Concordance index and receiver-operating characteristic curves were used to evaluate the clinical utility of the IASLC system for recurrence and death; the comparison was performed with the architectural-pattern system (the Arch system) and the grading system on the basis of the two most predominant patterns (the Sica's system).

RESULTS

Of 1002 patients with invasive ADC, 235 had recurrent disease and 166 died of lung cancer. The concordance index and area under the curve of the IASLC system were 0.777 and 0.807 for recurrence and 0.767 and 0.776 for death, respectively. These were similar to those of the Arch system (0.763 and 0.796 for recurrence, 0.743 and 0.755 for death) and the Sica's system (0.786 and 0.814 for recurrence, 0.762 and 0.773 for death).

CONCLUSIONS

We reported that the IASLC system for invasive lung ADC has prognostic significance by evaluating a large Japanese cohort. We believe that the IASLC grading system will provide physicians with better information for postsurgery treatment.

摘要

简介

国际肺癌研究协会(IASLC)病理学委员会于 2020 年 6 月提出了浸润性肺腺癌(ADC)的组织学分级系统。本研究评估了 IASLC 组织学分级系统(IASLC 系统)在大型日本队列中的预后价值。

方法

我们对完全切除的肺 ADC 患者进行了全面的组织学亚型分析,使用五种主要模式的半定量评估和复杂腺泡模式,并使用 IASLC 系统确定组织学分级。一致性指数和接收者操作特征曲线用于评估 IASLC 系统对复发和死亡的临床实用性;与架构模式系统(Arch 系统)和基于两种最主要模式的分级系统(Sica's 系统)进行比较。

结果

在 1002 例浸润性 ADC 患者中,235 例出现疾病复发,166 例死于肺癌。IASLC 系统的一致性指数和曲线下面积分别为 0.777 和 0.807,用于复发,分别为 0.767 和 0.776,用于死亡。这些结果与 Arch 系统(用于复发的 0.763 和 0.796,用于死亡的 0.743 和 0.755)和 Sica's 系统(用于复发的 0.786 和 0.814,用于死亡的 0.762 和 0.773)相似。

结论

我们通过评估一个大型日本队列报告了 IASLC 系统对浸润性肺 ADC 的预后意义。我们相信,IASLC 分级系统将为医生提供更好的术后治疗信息。

相似文献

1
Validation Study of the International Association for the Study of Lung Cancer Histologic Grading System of Invasive Lung Adenocarcinoma.浸润性肺腺癌国际肺癌研究协会组织学分级系统验证研究。
J Thorac Oncol. 2021 Oct;16(10):1753-1758. doi: 10.1016/j.jtho.2021.04.008. Epub 2021 Apr 24.
2
The new IASLC grading system for invasive non-mucinous lung adenocarcinoma is a more useful indicator of patient survival compared with previous grading systems.新的 IASLC 浸润性非黏液肺腺癌分级系统与既往分级系统相比,是一个更能预测患者生存的指标。
J Surg Oncol. 2023 Jan;127(1):174-182. doi: 10.1002/jso.27091. Epub 2022 Sep 13.
3
Validation Study of New IASLC Histology Grading System in Stage I Non-Mucinous Adenocarcinoma Comparing With Minimally Invasive Adenocarcinoma.新 IASLC 组织学分型系统在 I 期非黏液性腺癌中与微浸润性腺癌的验证研究
Clin Lung Cancer. 2022 Nov;23(7):e435-e442. doi: 10.1016/j.cllc.2022.06.004. Epub 2022 Jun 22.
4
Integrating IASLC grading and radiomics for predicting postoperative outcomes in stage IA invasive lung adenocarcinoma.IASLC 分级与放射组学相结合预测 IA 期浸润性肺腺癌术后结局。
Med Phys. 2024 Sep;51(9):6513-6524. doi: 10.1002/mp.17177. Epub 2024 May 23.
5
A Simplified Version of the IASLC Grading System for Invasive Pulmonary Adenocarcinomas With Improved Prognosis Discrimination.IASLC 肺浸润性腺癌分级系统简化版,提高了预后判别能力。
Am J Surg Pathol. 2023 Jun 1;47(6):686-693. doi: 10.1097/PAS.0000000000002040. Epub 2023 Apr 10.
6
High-grade tumor classified by new system is a prognostic predictor in resected lung adenocarcinoma.新系统分类的高级别肿瘤是肺腺癌切除术后的预后预测因子。
Gen Thorac Cardiovasc Surg. 2022 May;70(5):455-462. doi: 10.1007/s11748-021-01758-3. Epub 2022 Jan 20.
7
Proposal of a revised International Association for the Study of Lung Cancer grading system in pulmonary non-mucinous adenocarcinoma: The importance of the lepidic proportion.肺非黏液性腺癌中修订的国际肺癌研究协会分级系统的建议:贴壁生长比例的重要性。
Lung Cancer. 2023 Jan;175:1-8. doi: 10.1016/j.lungcan.2022.11.003. Epub 2022 Nov 8.
8
Frozen sections accurately predict the IASLC proposed grading system and prognosis in patients with invasive lung adenocarcinomas.冰冻切片能准确预测国际肺癌研究协会(IASLC)提出的浸润性肺腺癌患者分级系统及预后。
Lung Cancer. 2023 Apr;178:123-130. doi: 10.1016/j.lungcan.2023.02.010. Epub 2023 Feb 17.
9
Validation of the novel International Association for the Study of Lung Cancer grading system and prognostic value of filigree micropapillary and discohesive growth pattern in invasive pulmonary adenocarcinoma.新型国际肺癌研究协会分级系统的验证以及细网状微乳头和松散生长模式在浸润性肺腺癌中的预后价值
Lung Cancer. 2023 Jan;175:79-87. doi: 10.1016/j.lungcan.2022.11.022. Epub 2022 Dec 5.
10
Novel Insights Into the International Association for the Study of Lung Cancer Grading System for Lung Adenocarcinoma.肺腺癌国际肺癌研究协会分级系统的新见解。
Mod Pathol. 2024 Jul;37(7):100520. doi: 10.1016/j.modpat.2024.100520. Epub 2024 May 21.

引用本文的文献

1
Robotic-assisted bronchoscopy for histopathologic subtyping of primary lung adenocarcinoma.机器人辅助支气管镜检查用于原发性肺腺癌的组织病理学亚型诊断
Lung Cancer. 2025 Jul 28;207:108681. doi: 10.1016/j.lungcan.2025.108681.
2
A Comprehensive Evaluation of Clinicopathologic Characteristics, Molecular Features and Prognosis in Lung Adenocarcinoma with an Acinar Component.伴有腺泡成分的肺腺癌的临床病理特征、分子特征及预后的综合评估
Cancers (Basel). 2025 May 30;17(11):1825. doi: 10.3390/cancers17111825.
3
Clinical implication of tumor spread through air spaces in stage IA lung adenocarcinoma: prognostic impact and association with the International Association for the Study of Lung Cancer (IASLC) grade.
IA期肺腺癌肿瘤通过气腔播散的临床意义:预后影响及与国际肺癌研究协会(IASLC)分级的相关性
Transl Lung Cancer Res. 2025 Apr 30;14(4):1384-1394. doi: 10.21037/tlcr-2025-253. Epub 2025 Apr 27.
4
Integrating radiomics and deep learning for enhanced prediction of high-grade patterns in stage IA lung adenocarcinoma.整合放射组学与深度学习以增强对IA期肺腺癌高级别模式的预测
Transl Lung Cancer Res. 2025 Apr 30;14(4):1076-1088. doi: 10.21037/tlcr-24-995. Epub 2025 Apr 15.
5
CT radiomics from intratumor and peritumor regions for predicting poorly differentiated invasive nonmucinous pulmonary adenocarcinoma.来自肿瘤内和肿瘤周围区域的CT影像组学用于预测低分化浸润性非黏液性肺腺癌
Sci Rep. 2025 Apr 25;15(1):14434. doi: 10.1038/s41598-025-99465-z.
6
Differentiating high-grade patterns and predominant subtypes for IASLC grading in invasive pulmonary adenocarcinoma using radiomics and clinical-semantic features.利用影像组学和临床语义特征鉴别国际肺癌研究协会(IASLC)对浸润性肺腺癌分级中的高级别模式和主要亚型
Cancer Imaging. 2025 Mar 28;25(1):42. doi: 10.1186/s40644-025-00864-2.
7
Predictive value of perioperative carcinoembryonic antigen changes for recurrence in non-small cell lung cancer.围手术期癌胚抗原变化对非小细胞肺癌复发的预测价值
Transl Lung Cancer Res. 2025 Feb 28;14(2):398-407. doi: 10.21037/tlcr-24-776. Epub 2025 Feb 23.
8
Impact of histopathological subtypes on invasive lung adenocarcinoma: from epidemiology to tumour microenvironment to therapeutic strategies.组织病理学亚型对浸润性肺腺癌的影响:从流行病学到肿瘤微环境再到治疗策略
World J Surg Oncol. 2025 Feb 27;23(1):66. doi: 10.1186/s12957-025-03701-9.
9
Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in -Mutated Lung Adenocarcinoma.实体为主型组织学及癌相关成纤维细胞中高表达的血小板内皮细胞黏附分子预示EGFR突变型肺腺癌对奥希替尼的原发性耐药
JTO Clin Res Rep. 2024 Dec 18;6(3):100779. doi: 10.1016/j.jtocrr.2024.100779. eCollection 2025 Mar.
10
Application and progress of non-invasive imaging in predicting lung invasive non-mucinous adenocarcinoma under the new IASLC grading guidelines.非侵入性成像在新国际肺癌研究协会(IASLC)分级指南下预测肺浸润性非黏液腺癌中的应用与进展
Insights Imaging. 2025 Jan 2;16(1):4. doi: 10.1186/s13244-024-01877-4.